In the fall of 2025, the regions began offering newborns an injection of antibodies against RSV during the virus season. The initiative produced good results, with fewer cases and hospitalizations. This fall, it is being repeated for the very youngest. But the same virus that can be dangerous for young children also poses a risk to the elderly and people in risk groups.
For the elderly, people with weakened immune systems or chronic diseases, RSV can be dangerous and, in the worst case, cause a fatal infection. Unfortunately, there is currently no specific treatment for RSV, says Johan Westin, a virus researcher.
The virus spreads through droplets, and anyone who wants to avoid getting sick should steer clear of people who are coughing or sneezing. Since the symptoms are similar to those of a common cold - a cough, runny nose and sometimes a fever - it is difficult to know whether you have RSV. This can only be determined using respiratory samples analyzed in a lab.
Oxygen and pneumonia
Most people do not become seriously ill, but those who are severely affected may need extra oxygen and, in the worst case, a ventilator. Some also develop bacterial infections, such as pneumonia, as a complication of the viral infection.
Until now, it has taken time to determine how many people have been affected or needed hospital care because of RSV. However, from November 1 this year, the disease will be notifiable, meaning all positive lab results will be reported to the Swedish Public Health Agency.
This will make it easier to predict when the healthcare system will come under strain and when the virus may affect the population.
So we hope that people who seek care are tested properly, says Johan Westin.
Vaccine available
There are several effective vaccines against RSV. The Swedish Public Health Agency recommends that people over 75 and those in risk groups get vaccinated, preferably before the virus begins to spread.
It usually starts at the end of November or in December, with a peak in February or March, says Susanne Strömdahl, a specialist doctor at the vaccination unit at the Swedish Public Health Agency.
Those who want to get vaccinated against RSV must pay for it themselves, as the regions do not cover the cost. The price varies but is just over 2,000 kronor.
Johan Westin's advice for people who do not want to get infected, in addition to vaccination for those in risk groups, is the same as always:
Avoid meeting people who are coughing or sneezing. Droplet transmission is the main route of infection. And wash your hands to be on the safe side.








What do you think?